TABLE 3.
Prevalence of lpfAO113 among serogroups of EHEC, EPEC, and REPEC
| Pathotype | Serogroup | Presence of eaea | No. of strains positive for lpfAO113/no. tested |
|---|---|---|---|
| EHEC | O157:H7 | + | 0/2 |
| O111:H− | + | 3/4 | |
| O15:H− | + | 1/1 | |
| O26:H11 | + | 1/2 | |
| O147:H− | + | 1/1 | |
| O145:H25 | + | 1/1 | |
| O5:H− | + | 1/1 | |
| O113:H21 | − | 11/11 | |
| O116:H21 | − | 1/1 | |
| O130:H11 | − | 1/1 | |
| O5:H− | − | 2/2 | |
| O1:H7 | − | 0/1 | |
| NT:H7 | − | 1/1 | |
| NT:H− | − | 1/1 | |
| O48:H21 | − | 1/1 | |
| O76:H7 | − | 0/1 | |
| O128:H2 | − | 3/3 | |
| O91:H− | − | 2/2 | |
| O87:H16 | − | 1/1 | |
| OR:H− | − | 1/1 | |
| O123:H− | − | 1/1 | |
| EPEC | O127:H6 | + | 0/1 |
| O111:H2 | + | 0/2 | |
| O114:H2 | + | 0/1 | |
| O125:H2 | + | 0/1 | |
| O128:H2 | + | 0/1 | |
| O142:H6 | + | 0/2 | |
| O55:H7 | + | 0/1 | |
| O26:H− | + | 1/1 | |
| O86:H− | + | 0/1 | |
| REPEC | O15:H− | + | 2/2 |
| O103:H2 | + | 0/3 | |
| O153:H7 | + | 1/1 | |
| O20:H7 | + | 1/1 | |
| O8 | + | 0/1 | |
| O109:H2 | + | 0/1 |
a
Marker for LEE pathogenicity island.